Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 6
2005 5
2006 14
2007 16
2008 10
2009 18
2010 14
2011 18
2012 13
2013 21
2014 24
2015 25
2016 31
2017 34
2018 27
2019 22
2020 12
2021 22
2022 17
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Results by year

Filters applied: . Clear all
Page 1
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S, Bay J, Franz AR, Erhardt H, Klein L, Petzinger J, Binder C, Kirschenhofer S, Stein A, Hüning B, Heep A, Cloppenburg E, Muyimbwa J, Ott T, Sandkötter J, Teig N, Wiegand S, Schroth M, Kick A, Wurm D, Gebauer C, Linnemann K, Kittel J, Wieg C, Kiechl-Kohlendorfer U, Schmidt S, Böttger R, Thomas W, Brevis Nunez F, Stockmann A, Kriebel T, Müller A, Klotz D, Morhart P, Nohr D, Biesalski HK, Giannopoulou EZ, Hilt S, Poryo M, Wagenpfeil S, Haiden N, Ruckes C, Ehrlich A, Gortner L; NeoVitaA trial investigators. Meyer S, et al. Among authors: wagenpfeil s. Lancet Respir Med. 2024 Apr 18:S2213-2600(24)00073-0. doi: 10.1016/S2213-2600(24)00073-0. Online ahead of print. Lancet Respir Med. 2024. PMID: 38643780
Standardized Treatment and Diagnostic Approach to Reduce Disease burden in the early postoperative phase in children with congenital heart defects-STANDARD study: a pilot randomized controlled trial.
Vogt A, Meyer S, Schäfers HJ, Weise JJ, Wagenpfeil S, Abdul-Khaliq H, Poryo M. Vogt A, et al. Among authors: wagenpfeil s. Eur J Pediatr. 2023 Dec;182(12):5325-5340. doi: 10.1007/s00431-023-05191-x. Epub 2023 Sep 21. Eur J Pediatr. 2023. PMID: 37733115 Free PMC article. Clinical Trial.
Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry.
Abdin A, Anker SD, Cowie MR, Filippatos GS, Ponikowski P, Tavazzi L, Schöpe J, Wagenpfeil S, Komajda M, Böhm M. Abdin A, et al. Among authors: wagenpfeil s. Eur J Heart Fail. 2023 Nov;25(11):1985-1993. doi: 10.1002/ejhf.3023. Epub 2023 Sep 18. Eur J Heart Fail. 2023. PMID: 37661847
Assessment of an umbilical venous catheter dwell-time of 8-14 days versus 1-7 days in very low birth weight infacts (UVC - You Will See): a pilot single-center, randomized controlled trial.
Hess S, Poryo M, Ruckes C, Papan C, Ehrlich A, Ebrahimi-Fakhari D, Bay JS, Wagenpfeil S, Simon A, Meyer S. Hess S, et al. Among authors: wagenpfeil s. Early Hum Dev. 2023 Apr;179:105752. doi: 10.1016/j.earlhumdev.2023.105752. Epub 2023 Mar 17. Early Hum Dev. 2023. PMID: 36958105 Clinical Trial.
311 results